Acrux (ASX:ACR) Interest Expense : A$0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Acrux Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Acrux's interest expense for the six months ended in Jun. 2024 was A$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2024 was A$0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Acrux's Operating Income for the six months ended in Jun. 2024 was A$ -4.35 Mil. Acrux's Interest Expense for the six months ended in Jun. 2024 was A$ 0.00 Mil. GuruFocus does not calculate Acrux's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Acrux Interest Expense Historical Data

The historical data trend for Acrux's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux Interest Expense Chart

Acrux Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Interest Expense

Get a 7-Day Free Trial

Acrux Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Acrux Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Acrux (ASX:ACR) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Acrux's Interest Expense for the six months ended in Jun. 2024 was A$0.00 Mil. Its Operating Income for the six months ended in Jun. 2024 was A$-4.35 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2024 was A$1.92 Mil.

Acrux's Interest Coverage for the quarter that ended in Jun. 2024 is calculated as

GuruFocus does not calculate Acrux's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Acrux Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (ASX:ACR) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ARUXF:USA FJY:Germany

Address

103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003

Website

https://www.acrux.com.au

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.